Two Sigma Investments »

Rapt Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $898k 35k 25.79
2025-06-30 $349k 44k 8.00

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics